Table:
begin	end	state
1	29	cytoplasmic
30	48	transmembrane
49	58	non-cytoplasmic
59	81	transmembrane
82	88	cytoplasmic
89	108	transmembrane
109	113	non-cytoplasmic
114	137	transmembrane
138	157	cytoplasmic
158	178	transmembrane
179	189	non-cytoplasmic
190	210	transmembrane
211	230	cytoplasmic
231	253	transmembrane
254	259	non-cytoplasmic
260	280	transmembrane
281	286	cytoplasmic
287	306	transmembrane
307	325	non-cytoplasmic
326	344	transmembrane
345	352	cytoplasmic
353	372	transmembrane
373	377	non-cytoplasmic
378	402	transmembrane
403	412	cytoplasmic
413	435	transmembrane
436	446	non-cytoplasmic
447	465	transmembrane
466	477	cytoplasmic

Input:
>CCNA_01071
MTATTEATRLTPVARARAILGGSAGNLVEWYDWFAYAAFTLYFAPAFFPKGDQTVQLLQA
AAVFFLGFVARPIGAWIMGLYADHAGRRAALSVSVSLMCAGAFIIAITPDFQTIGLWAPA
ILLFARVLQGLSVGGEYGASATYMSEMAGKARRGFWSSFHYVTLIAGQLLALGVLIILQR
TLGEEALKEWAWRVPFIIGALLAVVVFWIRRGLEESVSFKRPAQSETLSRGQIISAGAFL
SLTIASGVVGLMGGPLAKAGQYLGAAFLVLFFVSLIVPLIRRHPRESLLIMGLTAGGSLT
FYVYTTYMQKFLVNTAGFSKAQASEISALSLIAFMLMQPLAGWLSDRFGRKPMLIIAFGG
GVLTIWPIMTAISQTNSVGVALALILVGVAFQSCYTAISAVVKAEMFPAEIRALGVALPY
ALANVLFGGTAEMVALAFKHENLESTFYVYVAAVMTIGLICSIILKDTGRHSLIHED

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server